In early breast cancer, all CTC‐positive (+) patients harbored IGF1R(+) CTCs, seven (25%) also had IGF1R‐negative (−) CTCs, and none presented exclusively IGF1R(−) CTCs. This evidence concerns the gene IGF1R and breast cancer.